Selected Recent Peer-Reviewed Publications

FitzGerald TJ. A new model for imaging and radiation therapy quality assurance in the National Clinical Trials Network of the National Cancer Institute. Int J Radiat Oncol Biol Phys. 2014;88(2):272-3.

Spalding AC, Hawkins DS, Donaldson SS, et al. The effect of radiation timing on patients with high-risk features of parameningeal rhabdomyosarcoma: an analysis of IRS-IV and
D9803. Int J Radiat Oncol Biol Phys. 2013;87(3):512-6.

Fairchild A, Straube W, Laurie F, Followill D. Does quality of radiation therapy predict outcomes of multicenter cooperative group trials? A literature review. Int J Radiat Oncol Biol Phys. 2013;87(2):246-60.

Fitzgerald TJ, Bishop-Jodoin M, Bosch WR, et al. Future vision for the quality assurance of oncology clinical trials. Front Oncol. 2013;3:31.

Followill DS, Urie M, Galvin JM, Ulin K, Xiao Y, Fitzgerald TJ. Credentialing for participation in clinical trials. Front Oncol. 2012;2:198.

Voss SD, Chen L, Constine LS, et al. Surveillance Computed Tomography Imaging and Detection of Relapse in Intermediate- and Advanced- Stage Pediatric Hodgkin's Lymphoma: A Report From the Children's Oncology Group. J Clin Oncol. 2012;30(21):2635-40.

Bekelman JE, Deye JA, Vikram B, et al. Redesigning radiotherapy quality assurance: opportunities to develop an efficient, evidence-based system to support clinical trials--report of the National Cancer Institute Work Group on Radiotherapy Quality Assurance. Int J Radiat Oncol Biol Phys. 2012;83(3):782-90.

Hoang T, Dahlberg SE, Schiller JH, et al. Randomized phase III study of thoracic radiation in combination with paclitaxel and carboplatin with or without thalidomide in patients with stage III non-small-cell lung cancer: the ECOG 3598 study. J Clin Oncol. 2012;30(6):616-22.

Lin C, Donaldson SS, Meza JL, et al. Effect of radiotherapy techniques (IMRT vs. 3D-CRT) on outcome in patients with intermediate-risk rhabdomyosarcoma enrolled in COG D9803--a report from the Children's Oncology Group. Int J Radiat Oncol Biol Phys. 2012;82(5):1764-70.

Million L, Anderson J, Breneman J, et al. Influence of noncompliance with radiation therapy protocol guidelines and operative bed recurrences for children with Rhabdomyosarcoma and microscopic residual disease: A report from the Children's Oncology Group. Int J Radiat Oncol Biol Phys. 2011;80(2):333-8.

Salama JK, Stinchcombe TE, Gu L, et al. Pulmonary toxicity in Stage III non-small cell lung cancer patients treated with high-dose (74 Gy) 3-dimensional conformal thoracic radiotherapy and concurrent chemotherapy following induction chemotherapy: A secondary analysis of Cancer and Leukemia Group B (CALGB) Trial 30105. Int J Radiat Oncol Biol Phys. 2011 Apr 6. [Epub ahead of print]

Peters LJ, O'Sullivan B, Giralt J, et al. Critical impact of radiotherapy protocol compliance and quality in the treatment of advanced head and neck cancer: results from TROG 02.02. J Clin Oncol. 2010;28(18):2996-3001.

Fitzgerald TJ, Bishop-Jodoin M, Cicchetti MG, et al. Quality of radiotherapy reporting in randomized controlled trials of Hodgkin's lymphoma and non-Hodgkin's lymphoma: in regard to Bekelman and Yahalom (Int J Radiat Oncol Biol Phys 2009;73:492-498). Int J Radiat Oncol Biol Phys. 2010;77(1):315-6.